Moderate Long-Term modulation of Neuropeptide Y in hypothalamic arcuate nucleus induces energy balance alterations in adult rats

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Sousa Ferreira, Lígia ^a,d   Garrido, Manuel ^a,b   Nascimento Ferreira, Isabel ^a,d   Nobrega, Clévio ^a   Santos Carvalho, Ana ^a,d   Álvaro, Ana Rita ^a,c   Rosmaninho Salgado, Joana ^a   Kaster, Manuella ^a   Kügler, Sebastian ^b   de Almeida, Pereira Luís ^a,d   Cavadas, Claudia ^a,d  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^c UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

^d UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; NEUROPEPTIDE Y; PARVOVIRUS VECTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARCUATE NUCLEUS; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DENSITOMETRY; DOWN REGULATION; FEEDBACK SYSTEM; FOOD INTAKE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HYPOTHALAMUS; IMMUNOREACTIVITY; IN VITRO STUDY; LIPID STORAGE; MALE; NEUROMODULATION; NONHUMAN; PHENOTYPE; PROTEIN LOCALIZATION; RAT; ADENO ASSOCIATED VIRUS; ADIPOGENESIS; ANIMAL; BLOOD; CELL SIZE; CELL STRAIN HEK293; CYTOLOGY; DIET RESTRICTION; EATING; ENERGY METABOLISM; GENE VECTOR; GENETICS; HYPERPHAGIA; METABOLISM; NERVE CELL; OBESITY; PHYSIOLOGY; TIME; WEIGHT GAIN; WISTAR RAT;

RATTUS;

ADIPOCYTES; ADIPOGENESIS; ANIMALS; ARCUATE NUCLEUS; CELL SIZE; DEPENDOVIRUS; DOWN-REGULATION; EATING; ENERGY METABOLISM; FASTING; FEEDBACK, PHYSIOLOGICAL; GENETIC VECTORS; HEK293 CELLS; HUMANS; HYPERPHAGIA; MALE; MICRORNAS; NEURONS; NEUROPEPTIDE Y; OBESITY; PPAR GAMMA; RATS; RATS, WISTAR; TIME FACTORS; WEIGHT GAIN;

EID: 79960672953     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022333     Document Type: Article

References (88)

1. Elmquist JK, Elias CF, Saper CB, (1999) From lesions to leptin: hypothalamic control of food intake and body weight. Neuron 22: 221-232.
2. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG, (2000) Central nervous system control of food intake. Nature 404: 661-671.
3. Chronwall BM, DiMaggio DA, Massari VJ, Pickel VM, Ruggiero DA, et al. (1985) The anatomy of neuropeptide-Y-containing neurons in rat brain. Neuroscience 15: 1159-1181.
4. Bi S, Robinson BM, Moran TH, (2003) Acute food deprivation and chronic food restriction differentially affect hypothalamic NPY mRNA expression. Am J Physiol Regul Integr Comp Physiol 285: R1030-1036.
5. White JD, Kershaw M, (1990) Increased hypothalamic neuropeptide Y expression following food deprivation. Mol Cell Neurosci 1: 41-48.
6. Broberger C, Visser TJ, Kuhar MJ, Hokfelt T, (1999) Neuropeptide Y innervation and neuropeptide-Y-Y1-receptor-expressing neurons in the paraventricular hypothalamic nucleus of the mouse. Neuroendocrinology 70: 295-305.
7. Wolak ML, DeJoseph MR, Cator AD, Mokashi AS, Brownfield MS, et al. (2003) Comparative distribution of neuropeptide Y Y1 and Y5 receptors in the rat brain by using immunohistochemistry. J Comp Neurol 464: 285-311.
8. Cowley MA, Pronchuk N, Fan W, Dinulescu DM, Colmers WF, et al. (1999) Integration of NPY, AGRP, and melanocortin signals in the hypothalamic paraventricular nucleus: evidence of a cellular basis for the adipostat. Neuron 24: 155-163.
9. Elias CF, Saper CB, Maratos-Flier E, Tritos NA, Lee C, et al. (1998) Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area. J Comp Neurol 402: 442-459.
10. Dhillon H, Kalra SP, Kalra PS, (2001) Dose-dependent effects of central leptin gene therapy on genes that regulate body weight and appetite in the hypothalamus. Mol Ther 4: 139-145.
11. Dryden S, King P, Pickavance L, Doyle P, Williams G, (1999) Divergent effects of intracerebroventricular and peripheral leptin administration on feeding and hypothalamic neuropeptide Y in lean and obese (fa/fa) Zucker rats. Clin Sci (Lond) 96: 307-312.
12. Keen-Rhinehart E, Desai M, Ross MG, (2009) Central insulin sensitivity in male and female juvenile rats. Horm Behav 56: 275-280.
13. Sahu A, (2002) Resistance to the satiety action of leptin following chronic central leptin infusion is associated with the development of leptin resistance in neuropeptide Y neurones. J Neuroendocrinol 14: 796-804.
14. Schwartz MW, Baskin DG, Bukowski TR, Kuijper JL, Foster D, et al. (1996) Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes 45: 531-535.
15. Schwartz MW, Seeley RJ, Campfield LA, Burn P, Baskin DG, (1996) Identification of targets of leptin action in rat hypothalamus. J Clin Invest 98: 1101-1106.
16. Schwartz MW, Sipols AJ, Marks JL, Sanacora G, White JD, et al. (1992) Inhibition of hypothalamic neuropeptide Y gene expression by insulin. Endocrinology 130: 3608-3616.
17. Sipols AJ, Baskin DG, Schwartz MW, (1995) Effect of intracerebroventricular insulin infusion on diabetic hyperphagia and hypothalamic neuropeptide gene expression. Diabetes 44: 147-151.
18. Baskin DG, Breininger JF, Schwartz MW, (1999) Leptin receptor mRNA identifies a subpopulation of neuropeptide Y neurons activated by fasting in rat hypothalamus. Diabetes 48: 828-833.
19. Mercer JG, Hoggard N, Williams LM, Lawrence CB, Hannah LT, et al. (1996) Coexpression of leptin receptor and preproneuropeptide Y mRNA in arcuate nucleus of mouse hypothalamus. J Neuroendocrinol 8: 733-735.
20. Obici S, Feng Z, Karkanias G, Baskin DG, Rossetti L, (2002) Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats. Nat Neurosci 5: 566-572.
21. Beck B, Jhanwar-Uniyal M, Burlet A, Chapleur-Chateau M, Leibowitz SF, et al. (1990) Rapid and localized alterations of neuropeptide Y in discrete hypothalamic nuclei with feeding status. Brain Res 528: 245-249.
22. Brady LS, Smith MA, Gold PW, Herkenham M, (1990) Altered expression of hypothalamic neuropeptide mRNAs in food-restricted and food-deprived rats. Neuroendocrinology 52: 441-447.
23. Mizuno TM, Mobbs CV, (1999) Hypothalamic agouti-related protein messenger ribonucleic acid is inhibited by leptin and stimulated by fasting. Endocrinology 140: 814-817.
24. Kalra SP, Dube MG, Sahu A, Phelps CP, Kalra PS, (1991) Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food. Proc Natl Acad Sci U S A 88: 10931-10935.
25. Sanchez E, Singru PS, Acharya R, Bodria M, Fekete C, et al. (2008) Differential effects of refeeding on melanocortin-responsive neurons in the hypothalamic paraventricular nucleus. Endocrinology 149: 4329-4335.
26. Xu B, Kalra PS, Farmerie WG, Kalra SP, (1999) Daily changes in hypothalamic gene expression of neuropeptide Y, galanin, proopiomelanocortin, and adipocyte leptin gene expression and secretion: effects of food restriction. Endocrinology 140: 2868-2875.
27. Sahu A, White JD, Kalra PS, Kalra SP, (1992) Hypothalamic neuropeptide Y gene expression in rats on scheduled feeding regimen. Brain Res Mol Brain Res 15: 15-18.
28. Dryden S, Pickavance L, Frankish HM, Williams G, (1995) Increased neuropeptide Y secretion in the hypothalamic paraventricular nucleus of obese (fa/fa) Zucker rats. Brain Res 690: 185-188.
29. Sanacora G, Kershaw M, Finkelstein JA, White JD, (1990) Increased hypothalamic content of preproneuropeptide Y messenger ribonucleic acid in genetically obese Zucker rats and its regulation by food deprivation. Endocrinology 127: 730-737.
30. Wilding JP, Gilbey SG, Bailey CJ, Batt RA, Williams G, et al. (1993) Increased neuropeptide-Y messenger ribonucleic acid (mRNA) and decreased neurotensin mRNA in the hypothalamus of the obese (ob/ob) mouse. Endocrinology 132: 1939-1944.
31. Chua SC Jr, Brown AW, Kim J, Hennessey KL, Leibel RL, et al. (1991) Food deprivation and hypothalamic neuropeptide gene expression: effects of strain background and the diabetes mutation. Brain Res Mol Brain Res 11: 291-299.
32. Yamamoto Y, Ueta Y, Date Y, Nakazato M, Hara Y, et al. (1999) Down regulation of the prepro-orexin gene expression in genetically obese mice. Brain Res Mol Brain Res 65: 14-22.
33. Stricker-Krongrad A, Kozak R, Burlet C, Nicolas JP, Beck B, (1997) Physiological regulation of hypothalamic neuropeptide Y release in lean and obese rats. Am J Physiol 273: R2112-2116.
34. Huang XF, Han M, Storlien LH, (2003) The level of NPY receptor mRNA expression in diet-induced obese and resistant mice. Brain Res Mol Brain Res 115: 21-28.
35. Wang J, Akabayashi A, Dourmashkin J, Yu HJ, Alexander JT, et al. (1998) Neuropeptide Y in relation to carbohydrate intake, corticosterone and dietary obesity. Brain Res 802: 75-88.
36. Hansen MJ, Jovanovska V, Morris MJ, (2004) Adaptive responses in hypothalamic neuropeptide Y in the face of prolonged high-fat feeding in the rat. J Neurochem 88: 909-916.
37. Lin S, Storlien LH, Huang XF, (2000) Leptin receptor, NPY, POMC mRNA expression in the diet-induced obese mouse brain. Brain Res 875: 89-95.
38. Ziotopoulou M, Mantzoros CS, Hileman SM, Flier JS, (2000) Differential expression of hypothalamic neuropeptides in the early phase of diet-induced obesity in mice. Am J Physiol Endocrinol Metab 279: E838-845.
39. Clark JT, Kalra PS, Kalra SP, (1985) Neuropeptide Y stimulates feeding but inhibits sexual behavior in rats. Endocrinology 117: 2435-2442.
40. Levine AS, Morley JE, (1984) Neuropeptide Y: a potent inducer of consummatory behavior in rats. Peptides 5: 1025-1029.
41. Stanley BG, Leibowitz SF, (1985) Neuropeptide Y injected in the paraventricular hypothalamus: a powerful stimulant of feeding behavior. Proc Natl Acad Sci U S A 82: 3940-3943.
42. Beck B, Stricker-Krongrad A, Nicolas JP, Burlet C, (1992) Chronic and continuous intracerebroventricular infusion of neuropeptide Y in Long-Evans rats mimics the feeding behaviour of obese Zucker rats. Int J Obes Relat Metab Disord 16: 295-302.
43. Zarjevski N, Cusin I, Vettor R, Rohner-Jeanrenaud F, Jeanrenaud B, (1993) Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity. Endocrinology 133: 1753-1758.
44. Tiesjema B, Adan RA, Luijendijk MC, Kalsbeek A, la Fleur SE, (2007) Differential effects of recombinant adeno-associated virus-mediated neuropeptide Y overexpression in the hypothalamic paraventricular nucleus and lateral hypothalamus on feeding behavior. J Neurosci 27: 14139-14146.
45. Tiesjema B, la Fleur SE, Luijendijk MC, Adan RA, (2009) Sustained NPY overexpression in the PVN results in obesity via temporarily increasing food intake. Obesity (Silver Spring) 17: 1448-1450.
46. Yang L, Scott KA, Hyun J, Tamashiro KL, Tray N, et al. (2009) Role of dorsomedial hypothalamic neuropeptide Y in modulating food intake and energy balance. J Neurosci 29: 179-190.
47. Erickson JC, Clegg KE, Palmiter RD, (1996) Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 381: 415-421.
48. Luquet S, Perez FA, Hnasko TS, Palmiter RD, (2005) NPY/AgRP neurons are essential for feeding in adult mice but can be ablated in neonates. Science 310: 683-685.
49. Gropp E, Shanabrough M, Borok E, Xu AW, Janoschek R, et al. (2005) Agouti-related peptide-expressing neurons are mandatory for feeding. Nat Neurosci 8: 1289-1291.
50. Mizuno TM, Kleopoulos SP, Bergen HT, Roberts JL, Priest CA, et al. (1998) Hypothalamic pro-opiomelanocortin mRNA is reduced by fasting and [corrected] in ob/ob and db/db mice, but is stimulated by leptin. Diabetes 47: 294-297.
51. Schwartz MW, Seeley RJ, Woods SC, Weigle DS, Campfield LA, et al. (1997) Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus. Diabetes 46: 2119-2123.
52. Tiesjema B, la Fleur SE, Luijendijk MC, Brans MA, Lin EJ, et al. (2007) Viral mediated neuropeptide Y expression in the rat paraventricular nucleus results in obesity. Obesity (Silver Spring) 15: 2424-2435.
53. Bray MS, Young ME, (2007) Circadian rhythms in the development of obesity: potential role for the circadian clock within the adipocyte. Obes Rev 8: 169-181.
54. Froy O, (2007) The relationship between nutrition and circadian rhythms in mammals. Front Neuroendocrinol 28: 61-71.
55. Laposky AD, Bradley MA, Williams DL, Bass J, Turek FW, (2008) Sleep-wake regulation is altered in leptin-resistant (db/db) genetically obese and diabetic mice. Am J Physiol Regul Integr Comp Physiol 295: R2059-2066.
56. Bagdade JD, Bierman EL, Porte D Jr, (1967) The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects. J Clin Invest 46: 1549-1557.
57. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, et al. (1996) Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334: 292-295.
58. Kristensen P, Judge ME, Thim L, Ribel U, Christjansen KN, et al. (1998) Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature 393: 72-76.
59. Thornton JE, Cheung CC, Clifton DK, Steiner RA, (1997) Regulation of hypothalamic proopiomelanocortin mRNA by leptin in ob/ob mice. Endocrinology 138: 5063-5066.
60. Acuna-Goycolea C, van den Pol AN, (2005) Peptide YY(3-36) inhibits both anorexigenic proopiomelanocortin and orexigenic neuropeptide Y neurons: implications for hypothalamic regulation of energy homeostasis. J Neurosci 25: 10510-10519.
61. Ghamari-Langroudi M, Colmers WF, Cone RD, (2005) PYY3-36 inhibits the action potential firing activity of POMC neurons of arcuate nucleus through postsynaptic Y2 receptors. Cell Metab 2: 191-199.
62. King PJ, Widdowson PS, Doods HN, Williams G, (1999) Regulation of neuropeptide Y release by neuropeptide Y receptor ligands and calcium channel antagonists in hypothalamic slices. J Neurochem 73: 641-646.
63. Cowley MA, Smart JL, Rubinstein M, Cerdan MG, Diano S, et al. (2001) Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 411: 480-484.
64. Roseberry AG, Liu H, Jackson AC, Cai X, Friedman JM, (2004) Neuropeptide Y-mediated inhibition of proopiomelanocortin neurons in the arcuate nucleus shows enhanced desensitization in ob/ob mice. Neuron 41: 711-722.
65. Raposinho PD, Castillo E, d'Alleves V, Broqua P, Pralong FP, et al. (2000) Chronic blockade of the melanocortin 4 receptor subtype leads to obesity independently of neuropeptide Y action, with no adverse effects on the gonadotropic and somatotropic axes. Endocrinology 141: 4419-4427.
66. Raposinho PD, Pierroz DD, Broqua P, White RB, Pedrazzini T, et al. (2001) Chronic administration of neuropeptide Y into the lateral ventricle of C57BL/6J male mice produces an obesity syndrome including hyperphagia, hyperleptinemia, insulin resistance, and hypogonadism. Mol Cell Endocrinol 185: 195-204.
67. Dhillo WS, Small CJ, Stanley SA, Jethwa PH, Seal LJ, et al. (2002) Hypothalamic interactions between neuropeptide Y, agouti-related protein, cocaine- and amphetamine-regulated transcript and alpha-melanocyte-stimulating hormone in vitro in male rats. J Neuroendocrinol 14: 725-730.
68. Elias CF, Kelly JF, Lee CE, Ahima RS, Drucker DJ, et al. (2000) Chemical characterization of leptin-activated neurons in the rat brain. J Comp Neurol 423: 261-281.
69. El-Haschimi K, Pierroz DD, Hileman SM, Bjorbaek C, Flier JS, (2000) Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity. J Clin Invest 105: 1827-1832.
70. Munzberg H, Flier JS, Bjorbaek C, (2004) Region-specific leptin resistance within the hypothalamus of diet-induced obese mice. Endocrinology 145: 4880-4889.
71. Enriori PJ, Evans AE, Sinnayah P, Jobst EE, Tonelli-Lemos L, et al. (2007) Diet-induced obesity causes severe but reversible leptin resistance in arcuate melanocortin neurons. Cell Metab 5: 181-194.
72. Sahu A, (2008) Effects of chronic central leptin infusion on proopiomelanocortin and neurotensin gene expression in the rat hypothalamus. Neurosci Lett 440: 125-129.
73. Ye J, Gao Z, Yin J, He Q, (2007) Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am J Physiol Endocrinol Metab 293: E1118-1128.
74. Yin J, Gao Z, He Q, Zhou D, Guo Z, et al. (2009) Role of hypoxia in obesity-induced disorders of glucose and lipid metabolism in adipose tissue. Am J Physiol Endocrinol Metab 296: E333-342.
75. Wang B, Wood IS, Trayhurn P, (2008) Hypoxia induces leptin gene expression and secretion in human preadipocytes: differential effects of hypoxia on adipokine expression by preadipocytes. J Endocrinol 198: 127-134.
76. Yun Z, Maecker HL, Johnson RS, Giaccia AJ, (2002) Inhibition of PPAR gamma 2 gene expression by the HIF-1-regulated gene DEC1/Stra13: a mechanism for regulation of adipogenesis by hypoxia. Dev Cell 2: 331-341.
77. Davy KP, Orr JS, (2009) Sympathetic nervous system behavior in human obesity. Neurosci Biobehav Rev 33: 116-124.
78. Kuo LE, Kitlinska JB, Tilan JU, Li L, Baker SB, et al. (2007) Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome. Nat Med 13: 803-811.
79. Lundberg JM, Martinsson A, Hemsen A, Theodorsson-Norheim E, Svedenhag J, et al. (1985) Co-release of neuropeptide Y and catecholamines during physical exercise in man. Biochem Biophys Res Commun 133: 30-36.
80. Li G, Mobbs CV, Scarpace PJ, (2003) Central pro-opiomelanocortin gene delivery results in hypophagia, reduced visceral adiposity, and improved insulin sensitivity in genetically obese Zucker rats. Diabetes 52: 1951-1957.
81. Li G, Zhang Y, Wilsey JT, Scarpace PJ, (2005) Hypothalamic pro-opiomelanocortin gene delivery ameliorates obesity and glucose intolerance in aged rats. Diabetologia 48: 2376-2385.
82. Pierce AA, Xu AW, De novo neurogenesis in adult hypothalamus as a compensatory mechanism to regulate energy balance. J Neurosci 30: 723-730.
83. Gardiner JV, Kong WM, Ward H, Murphy KG, Dhillo WS, et al. (2005) AAV mediated expression of anti-sense neuropeptide Y cRNA in the arcuate nucleus of rats results in decreased weight gain and food intake. Biochem Biophys Res Commun 327: 1088-1093.
84. Kurreck J, (2003) Antisense technologies. Improvement through novel chemical modifications. Eur J Biochem 270: 1628-1644.
85. McBride JL, Boudreau RL, Harper SQ, Staber PD, Monteys AM, et al. (2008) Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi. Proc Natl Acad Sci U S A 105: 5868-5873.
86. Malik JM, Shevtsova Z, Bahr M, Kugler S, (2005) Long-term in vivo inhibition of CNS neurodegeneration by Bcl-XL gene transfer. Mol Ther 11: 373-381.
87. Shevtsova Z, Malik JM, Michel U, Bahr M, Kugler S, (2005) Promoters and serotypes: targeting of adeno-associated virus vectors for gene transfer in the rat central nervous system in vitro and in vivo. Exp Physiol 90: 53-59.
88. Kugler S, Kilic E, Bahr M, (2003) Human synapsin 1 gene promoter confers highly neuron-specific long-term transgene expression from an adenoviral vector in the adult rat brain depending on the transduced area. Gene Ther 10: 337-347.